查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827726

2025年全球藥物篩檢市場報告

Drug Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物篩檢市場規模迅速擴張，從2024年的85.7億美元成長到2025年的97.2億美元，複合年成長率達13.3%。在此期間，成長主要源自於藥物檢測、醫療保健和臨床診斷、藥物濫用治療、研發投入以及藥物檢測套組和設備使用量的增加。

預計未來幾年藥物篩檢市場將快速成長，到2029年將達到168.6億美元，年複合成長率(CAGR)為14.8%。預測期內的成長可歸因於大麻合法化和鴉片類藥物危機、體育賽事的興起、照護現場和快速檢測、不斷變化的藥物政策和法規、職場健康和健康計劃的擴展以及國際市場的擴張。預測期內的主要趨勢包括先進的藥物檢測技術、遠端醫療和遠端檢測、研發投資、創新藥物檢測套組和設備以及檢測技術的進步。

藥物篩檢是一種專門為臨床試驗設計和最佳化的藥物檢測方法。它透過分析血液、尿液、頭髮和唾液來檢測因吸毒而殘留在體內的化學物質、污染物和其他非法物質。

藥物篩檢產品的主要類型包括快速檢測設備、耗材和其他相關產品。快速檢測設備是一種使用者友好的篩檢工具，比傳統的實驗室檢測更快提供結果。藥物篩檢使用各種樣本，包括口腔液、頭髮、尿液和呼吸。這些篩檢適用於藥物檢測實驗室、職場、刑事司法和執法機構、醫院、藥物治療中心、個人使用者、疼痛管理中心、學校和大學。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供藥物篩檢市場統計數據，例如全球藥物篩檢行業市場規模、各地區市場佔有率、各競爭對手的篩檢篩檢市場、市場趨勢和商機，以及您在藥物篩檢行業取得成功所需的數據。本藥物篩檢市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為14.8%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接影響美國，導致篩檢電離源和高通量篩選板的供應鏈中斷，這些產品主要來自加拿大和丹麥等關鍵地區，這可能會延遲藥物開發並增加藥物研發成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，這種影響也可能更為廣泛。

預計藥物篩檢市場的成長將受到藥物和酒精消費量增加的推動。藥物成癮是一種影響大腦和行為的疾病，導致不受控制地使用合法或非法物質，例如酒精、大麻和尼古丁。隨著藥物和酒精成癮率的上升，相關的健康風險也在增加，因此需要進行藥物篩檢。 2022 年，全球對藥物和酒精消費的擔憂依然強烈，全國藥物使用和健康調查 (NSDUH) 報告稱，12 歲及以上美國人的藥物使用率同比成長 3.8%。此外，該年齡層中 21.4% 的人報告在過去一年中使用過非法藥物或濫用處方箋藥。持續的疫情進一步加劇了毒品風險，某些地區年輕人的大麻消費量增加了四倍。藥物和酒精消費量的增加極大地促進了藥物篩檢市場的成長。

預計未來藥物濫用治療需求的不斷成長將推動藥物篩檢市場的成長。藥物濫用是指使用有害物質，其劑量足以對使用者和他人造成不利影響。藥物篩檢有助於識別體內通常不存在的化合物。這個過程始於篩檢測試，然後進行二次測試以檢測和確認特定物質。因此，藥物濫用治療需求的不斷成長將支持市場擴張。例如，根據美國衛生與公共服務部2023年8月發布的報告，美國有超過2,700萬人報告近期非法使用藥物或濫用處方藥。此外，近四分之一的成年人和青少年承認在過去一個月內有過酗酒和飲酒行為。據估計，藥物濫用每年造成的經濟損失（酒精）為2,490億美元，非法藥物為1,930億美元。因此，在預測期內，藥物濫用治療需求的不斷成長將推動藥物篩檢市場的成長。

藥物篩檢市場的一個顯著趨勢是創新產品的推出。該領域的主要企業正在積極開發和推出創新產品，以滿足快速成長的行業需求並鞏固其市場地位。 COVID-19 疫情改變了藥物篩檢的方法，刺激了創新和新產品的開發。各公司正努力為實驗室創造更有效、更廣泛適用的藥物檢測方法。例如，2022 年 9 月，日本醫療保健公司 Sysmex Corporation 推出了 UF-1500 全自動尿液顆粒分析儀。這款專為尿沉渣檢測和篩檢設計的創新產品繼承了 UF-5000 全自動尿液顆粒分析儀的功能和易用性，同時實現了更緊湊的尺寸。這體現了藥物篩檢市場創新產品發布的趨勢。

藥物篩檢市場中的公司擴大將策略夥伴關係和聯盟視為加強財務狀況、增強產品系列和擴大地理覆蓋範圍的手段。策略聯盟是兩方或多方之間達成的協議，旨在共同追求商定的目標，同時維持組織獨立性。例如，2022 年 12 月，英國生物製藥公司 PhoreMost Ltd. 和日本生物技術公司 ThinkCyte Inc. 宣佈建立策略研究聯盟，專注於透過應用人工智慧 (AI) 在表現型分析方面的最新進展。該聯盟將 PhoreMost 的 SITESEEKER 平台（旨在識別適合未來治療方法的新標靶）與 ThinkCyte 的 Ghost Cytometry 技術（一種由 AI 驅動的細胞表徵和分選平台）相結合。透過結合這些創新技術，該夥伴關係關係旨在提高表現型分析的效率和有效性。透過利用人工智慧和機器學習，該聯盟有可能識別新的藥物標靶並加速有效療法的開發。

2022年4月，Saladax Biomedical, Inc.（一家專注於開發、生產和銷售快速測定治療藥物濃度的美國公司）從比利時製藥公司楊森製藥（Janssen Pharmaceutica NV）收購了與抗精神病藥物檢測和篩檢相關的專利組合。此次收購使Saladax能夠開發與醫院常用化學分析儀以及適用於無法進行集中檢測的場所的即時診斷設備相容的檢測方法。這些檢測方法透過為醫療保健專業人員提供快速、可操作的結果，解決了嚴重精神疾病 (SMI) 患者尚未滿足的重大臨床需求。此次合作體現了策略性收購如何有助於滿足臨床需求並擴大藥物篩檢市場的產品供應。

參與藥物篩檢市場的主要企業包括 Laboratory Corporation、Quest Diagnostics Incorporated、OraSure Technologies Inc.、Alfa Scientific Designs Inc.、Abbott Laboratories、Thermo Fisher Scientific Inc.、Dragerwerk AG & Co. KGaA、LifeLoc Technologies Inc.、MPD Inc.、Omeics Inc. Roche Ltd.、Shimadzu Corporation、Siemens Healthineers AG、Medtox Scientific Inc.、American Screening Corporation、Clinical Reference Laboratory Inc、Express Diagnostics International Inc.、Global Drug Testing Services、Kroll Laboratory Specialists Inc.、Medscreen Laboratories Global、National Scrlin Services、Kroll Laboratory Specialists Inc.、Medscreen Laboratories、National Scrlin Services、Krolls、MACcani​​stals Eaborscreen Laboratories、N 它Laboratories、Intertek Group plc 和 Eurofins Scientific SE。

2024年藥物篩檢市場最大的地區是北美。預計亞太地區將成為預測期內藥物篩檢市場成長最快的地區。藥物篩檢市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

藥物篩檢市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

藥物篩檢市場包括檢測套組、試劑和其他耗材的銷售。該市場的價值指的是“出廠價”，即商品製造商或創造者出售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接出售給最終客戶的價值。該市場中的商品價值還包括商品創造者出售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥物篩檢：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球藥物篩檢市場：成長率分析
  • 全球藥物篩檢市場表現：規模與成長，2019-2024
  • 全球藥物篩檢市場預測：規模與成長，2024-2029年，2034年
  • 全球藥物篩檢：總目標市場（TAM）

第6章 市場細分

  • 全球藥物篩檢市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 快速檢測裝置
  • 耗材
  • 其他產品
  • 全球藥物篩檢市場（按樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 口腔液體樣本
  • 頭髮樣本
  • 尿液樣本
  • 呼氣樣本
  • 其他樣本類型
  • 全球藥物篩檢市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物檢測實驗室
  • 職場
  • 刑事司法和執法
  • 醫院
  • 戒毒中心
  • 個人用戶
  • 疼痛管理中心
  • 學校和大學
  • 全球藥物篩檢市場：按快速檢測設備（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 尿液藥物檢測套組
  • 唾液藥物檢測套組
  • 血液藥物檢測設備
  • 即時測試條
  • 全球藥物篩檢市場：按耗材（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑和測定法
  • 採樣裝置
  • 校準標準
  • 全球藥物篩檢市場：依產品類型細分、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 實驗設備
  • 軟體解決方案
  • 儲存和運輸解決方案

第7章 區域和國家分析

  • 全球藥物篩檢市場：區域分析、預測與成長，2019-2024 年、2024-2029 年、2034 年
  • 全球藥物篩檢市場：依國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 藥物篩檢市場：競爭格局
  • 藥物篩檢市場：公司簡介
    • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Thermo Fisher Scientific Inc.
  • Dragerwerk AG & Co. KGaA
  • LifeLoc Technologies Inc.
  • MPD Inc.
  • Omega Laboratories Inc.
  • Premier Biotech Inc.
  • Psychemedics Corporation
  • F. Hoffmann-La Roche Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Medtox Scientific Inc.
  • American Screening Corporation
  • Clinical Reference Laboratory Inc.
  • Express Diagnostics International Inc.
  • Global Drug Testing Services

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年藥物篩檢市場：提供新機會的國家
  • 2029年藥物篩檢市場：細分領域帶來新機會
  • 2029年藥物篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21389u

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $8.57 billion in 2024 to $9.72 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $16.86 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to legalization of cannabis and opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The forecast of 14.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mass spectrometry ionization sources and high-throughput screening plates, sourced from key regions such as Canada and Denmark, which could lead to slower pharmaceutical development and increased drug discovery expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The increasing demand for substance abuse treatment is expected to drive the growth of the drug screening market in the future. Substance abuse refers to the harmful use of a substance in quantities that negatively affect the user or others. Drug screening helps identify compounds that are typically not present in the body. The process begins with a screening test, which is followed by a secondary test to detect and/or confirm the presence of specific substances, so the growing demand for drug abuse treatment will support market expansion. For example, in August 2023, a report from the U.S. Department of Health and Human Services indicated that over 27 million people in the United States had recently reported using illicit drugs or misusing prescription medications. Furthermore, nearly a quarter of both adults and adolescents admitted to binge drinking in the past month. The annual economic cost of substance misuse is estimated at $249 billion for alcohol and $193 billion for illicit drugs. Therefore, the rising need for substance abuse treatment is propelling the growth of the drug screening market during the forecast period.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Subsegments:
  • 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
  • 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
  • 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Dragerwerk AG & Co. KGaA; LifeLoc Technologies Inc.; MPD Inc.; Omega Laboratories Inc.; Premier Biotech Inc.; Psychemedics Corporation; F. Hoffmann-La Roche Ltd.; Shimadzu Corporation; Siemens Healthineers AG; Medtox Scientific Inc.; American Screening Corporation; Clinical Reference Laboratory Inc.; Express Diagnostics International Inc.; Global Drug Testing Services; Kroll Laboratory Specialists Inc.; Medscreen Laboratories; National Screening Centers Inc.; American Bio Medica Corporation; Mayo Clinic Laboratories; ACM Global Laboratories; Intertek Group plc; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Screening Market Growth Rate Analysis
  • 5.4. Global Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Screening Total Addressable Market (TAM)

6. Drug Screening Market Segmentation

  • 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Testing Devices
  • Consumables
  • Other Products
  • 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Fluid Sample
  • Hair Sample
  • Urine Sample
  • Breath Sample
  • Other Sample Types
  • 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • 6.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Test Kits
  • Saliva Drug Test Kits
  • Blood Drug Test Devices
  • Instant Test Strips
  • 6.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents and Assays
  • Sample Collection Devices
  • Calibration Standards
  • 6.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Equipment
  • Software Solutions
  • Storage and Transport Solutions

7. Drug Screening Market Regional And Country Analysis

  • 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Screening Market

  • 8.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Screening Market

  • 9.1. China Drug Screening Market Overview
  • 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Screening Market

  • 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Screening Market

  • 11.1. Japan Drug Screening Market Overview
  • 11.2. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Screening Market

  • 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Screening Market

  • 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Screening Market

  • 14.1. South Korea Drug Screening Market Overview
  • 14.2. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Screening Market

  • 15.1. Western Europe Drug Screening Market Overview
  • 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Screening Market

  • 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Screening Market

  • 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Screening Market

  • 18.1. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Screening Market

  • 19.1. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Screening Market

  • 20.1. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Screening Market

  • 21.1. Eastern Europe Drug Screening Market Overview
  • 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Screening Market

  • 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Screening Market

  • 23.1. North America Drug Screening Market Overview
  • 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Screening Market

  • 24.1. USA Drug Screening Market Overview
  • 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Screening Market

  • 25.1. Canada Drug Screening Market Overview
  • 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Screening Market

  • 26.1. South America Drug Screening Market Overview
  • 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Screening Market

  • 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Screening Market

  • 28.1. Middle East Drug Screening Market Overview
  • 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Screening Market

  • 29.1. Africa Drug Screening Market Overview
  • 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug Screening Market Competitive Landscape
  • 30.2. Drug Screening Market Company Profiles
    • 30.2.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Drug Screening Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Dragerwerk AG & Co. KGaA
  • 31.3. LifeLoc Technologies Inc.
  • 31.4. MPD Inc.
  • 31.5. Omega Laboratories Inc.
  • 31.6. Premier Biotech Inc.
  • 31.7. Psychemedics Corporation
  • 31.8. F. Hoffmann-La Roche Ltd.
  • 31.9. Shimadzu Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Medtox Scientific Inc.
  • 31.12. American Screening Corporation
  • 31.13. Clinical Reference Laboratory Inc.
  • 31.14. Express Diagnostics International Inc.
  • 31.15. Global Drug Testing Services

32. Global Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Recent Developments In The Drug Screening Market

35. Drug Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer